epiClinical is fictional. It is a portfolio demonstration by Adam Daniels. Its studies, sponsors, sites and enrolment figures are synthetic. The evidence behind its assumptions is real, and every number says how far it can be trusted.
EPI-620, Phase III. In planning
Chronic obstructive pulmonary disease with frequent exacerbations
LWR-620 against placebo to reduce exacerbations in COPD. Sponsor: Litware Respiratory (fictional), Respiratory.
EPI-620 has no sites yet, so there is nothing to measure. Its KPIs start once sites are selected and open.